Bioprocessing of bacteriophages via rapid drying onto microcrystals

Biotechnology Progress

Volumn 28, Issue 2, 2012, Pages 540-548

  Alvarez Gonzalez, Eva ^a   Alfadhel, Munerah ^a   Mane, Parag ^a   Ford, Steven J ^a   Moore, Barry D ^a   van der Walle, Christopher F ^a  

^a UNIVERSITY OF STRATHCLYDE   (United Kingdom)

Author keywords

Bacteriophages; Bioprocessing; Immobilization; Protein coated microcrystals; Staphylococcus aureus

Indexed keywords

AQUEOUS MIXTURES; BIOPROCESSES; BIOPROCESSING; DRY POWDERS; FREE FLOWING; ISO-PROPANOLS; ISOBUTANOL; MICROCARRIERS; PHAGE THERAPY; PROTEIN-COATED MICROCRYSTALS; RAPID DRYING; RESIDUAL SOLVENTS; ROOM TEMPERATURE; STAPHYLOCOCCUS AUREUS; WATER-MISCIBLE ORGANIC SOLVENTS;

AMINO ACIDS; BACTERIA; FILTRATION; MICROCRYSTALS; ORGANIC SOLVENTS; POLYETHYLENE GLYCOLS; RADIOACTIVE WASTE VITRIFICATION; SUGAR (SUCROSE);

BACTERIOPHAGES;

CRYOPROTECTIVE AGENT;

ARTICLE; CHEMISTRY; DRUG EFFECT; EVALUATION; FREEZE DRYING; METHODOLOGY; PHYSIOLOGY; STAPHYLOCOCCUS PHAGE; SURFACE PROPERTY; TEMPERATURE;

CRYOPROTECTIVE AGENTS; FREEZE DRYING; STAPHYLOCOCCUS PHAGES; SURFACE PROPERTIES; TEMPERATURE;

SIPHOVIRIDAE; STAPHYLOCOCCUS AUREUS;

EID: 84859629404     PISSN: 87567938     EISSN: 15206033     Source Type: Journal    
DOI: 10.1002/btpr.740     Document Type: Article

References (37)

1. Jackson RE. Bacteriophage prevention and control of harmful plant bacteria. Patent number CA-1306671, 1992.
2. Smith HW, Huggins MB. Effectiveness of phages in treating experimental Escherichia coli diarrhoea in calves, piglets and lambs. J Gen Microbiol. 1983; 129: 2659-2675.
3. Soothill J, Hawkins C, Anggard E, Harper D. Therapeutic use of bacteriophages. Lancet Infect Dis. 2004; 4: 544-545.
4. Hagens S, Loessner MJ. Application of bacteriophages for detection and control of foodborne pathogens. Appl Microbiol Biotechnol. 2007; 76: 513-519.
5. Barrow PA, Soothill JS. Bacteriophage therapy and prophylaxis: rediscovery and renewed assessment of potential. Trends Microbiol. 1997; 5: 268-271.
6. Sulakvelidze A, Alavidze Z, Morris JGJr. Bacteriophage therapy. Antimicrob Agents Chemother. 2001; 45: 649-659.
7. Hanlon GW. Bacteriophages: an appraisal of their role in the treatment of bacterial infections. Int J Antimicrob Agents. 2007; 30: 118-128.
8. Skurnik M, Pajunen M, Kiljunen S. Biotechnological challenges of phage therapy. Biotechnol Lett. 2007; 29: 995-1003.
9. Carlton RM, Noordman WH, Biswas B, de Meester ED, Loessner MJ. Bacteriophage P100 for control of Listeria monocytogenes in foods: genome sequence, bioinformatic analyses, oral toxicity study, and application. Regul Toxicol Pharmacol. 2005; 43: 301-312.
10. Wright A, Hawkins CH, Anggard EE, Harper DR. A controled clinical trial of a therapeutic bacteriophage perparation in chronic otitis due to antibiotic-resistant Pseudomonas aeruginosa: a preliminary report of efficacy. Clin Otolaryngol. 2009; 34: 349-357.
11. Harding SE. Some observations on the effects of bioprocessing on biopolymer stability. J Drug Target. 2010; 18: 732-740.
12. Cromwell MEM, Hilario E, Jacobson F. Protein aggregation and bioprocessing. AAPS J. 2006; 8: E572-E579.
13. Clark WA, Geary D. Proceedings: preservation of bacteriophages by freezing and freeze-drying. Cryobiology. 1973; 10: 351-360.
14. Golshahi L, Lynch KH, Dennis JJ, Finlay WH. In vitro lung delivery of bacteriophages KS4-M and PhiKZ using dry powder inhalers for treatment of Burkholderia cepacia complex and Pseudomonas aeruginosa infections in cystic fibrosis. J Appl Microbiol. 2010; 110: 106-117.
15. Ackermann H-W, Tremblay D, Moineau S. Long-term bacteriophage preservation. World Federation Cult Collections Newsl. 2004; 38: 35-40.
16. Gould EA. Methods for long-term virus preservation. Mol Biotechnol. 1999; 13: 57-66.
17. Puapermpoonsiri U, Ford SJ, van der Walle CF. Stabilization of bacteriophage during freeze drying. Int J Pharm. 2010; 389: 168-175.
18. Puapermpoonsiri U, Spencer J, van der Walle CF. A freeze-dried formulation of bacteriophage encapsulated in biodegradable microspheres. Eur J Pharm Biopharm. 2009; 72: 26-33.
19. Golec P, Dabrowski K, Hejnowicz MS, Gozdek A, Los JM, Wegrzyn G, Lobocka MB, Los M. A reliable method for storage of tailed phages. J Microbiol Methods 2011; 84: 486-489.
20. Moore BD, Parker MC, Halling PJ, Partridge J, Stevens HNE. Rapid dehydration of proteins. Patent number WO-0069887, 2000.
21. Kreiner M, Moore BD, Parker MC. Enzyme-coated micro-crystals: a 1-step method for high activity biocatalyst preparation. Chem Commun. (Camb.) 2001: 1096-1097.
22. Kreiner M, Fuglevand G, Moore BD, Parker MC. DNA-coated microcrystals. Chem Commun. (Camb.) 2005: 2675-2676.
23. Murugesan M, Cunningham D, Martinez-Albertos JL, Vrcelj RM, Moore BD. Nanoparticle-coated microcrystals. Chem Commun. (Camb.) 2005: 2677-2679.
24. Alfadhel M, Puapermpoonsiri U, Ford SJ, McInnes FJ, van der Walle CF. Lyophilized inserts for nasal administration harboring bacteriophage selective for Staphylococcus aureus: in vitro evaluation. Int J Pharm. 2011; 416: 280-287.
25. Cappuccino JG, Sherman N. Microbiology: A Laboratory Manual. Benjamin Cummings (9th Ed.), 2011.
26. Matsubara T, Emoto W, Kawashiro K. A simple two-transition model for loss of infectivity of phages on exposure to organic solvent. Biomol Eng. 2007; 24: 269-271.
27. Pereira P, Kelly SM, Cooper A, Mardon HJ, Gellert PR, van der Walle CF. Solution formulation and lyophilization of a recombinant fibronectin fragment. Eur J Pharm Biopharm. 2007; 67: 309-319.
28. Annan WS, Fairhead M, Pereira P, van der Walle CF. Emulsifying performance of modular beta-sandwich proteins: the hydrophobic moment and conformational stability. Protein Eng Des Sel. 2006; 19: 537-545.
29. Lee JC, Timasheff SN. The stabilization of proteins by sucrose. J Biol Chem. 1981; 256: 7193-7201.
30. Wang W, Antonsen K, Nayar R. A novel method for removing residual acetone from gelatin microspheres. Pharm Dev Technol. 2002; 7: 169-180.
31. Mattern M, Winter G, Kohnert U, Lee G. Formulation of proteins in vacuum-dried glasses. II. Process and storage stability in sugar-free amino acid systems. Pharm Dev Technol. 1999; 4: 199-208.
32. Breen ED, Curley JG, Overcashier DE, Hsu CC, Shire SJ. Effect of moisture on the stability of a lyophilized humanized monoclonal antibody formulation. Pharm Res. 2001; 18: 1345-1353.
33. Griebenow K, Klibanov AM. On protein denaturation in aqueous-organic mixtures but not in pure organic solvents. J Am Chem Soc. 1996; 118: 11695-11700.
34. Kreiner M, Parker MC. High-activity biocatalysts in organic media: solid-state buffers as the immobilization matrix for protein-coated microcrystals. Biotechnol Bioeng. 2004; 87: 24-33.
35. Moore BD, Deere J, Edrada-Ebel R, Ingram A, van der Walle CF. Isolation of recombinant proteins from culture broth by co-precipitation with an amino acid carrier to form stable dry powders. Biotechnol Bioeng. 2010; 106: 764-773.
36. Schussele A, Bauer-Brandl A. Note on the measurement of flowability according to the European Pharmacopoeia. Int J Pharm. 2003; 257: 301-304.
37. Lawton S, Steele G, Shering P, Zhao LH, Laird I, Ni XW. Continuous crystallization of pharmaceuticals using a continuous oscillatory baffled crystallizer. Org Process Res Dev. 2009; 13: 1357-1363.